|
1
|
Li JQ, Zhang QJ and Li B: Research
progress of diagnosis and treatment of vertebral basilar artery
blood supply deficiency. Zhong Wai Yi Xue Yan Jiu. 30:154–156.
2011.(In Chinese).
|
|
2
|
Chang WL: 130 case analysis of diagnosis
and treatment of vertebral-basilar artery blood supply
insufficiency. Shaanxi Yi Xue Za Zhi. 39:1039–1040. 2010.(In
Chinese).
|
|
3
|
Li L, Yu LX and Sui P: Curative effect
observation of buflomedil hydrochloride combined with shuxuening in
the treatment of posterior circulation ischemic vertigo. Zhongguo
Shi Yong Shen Jing Ji Bing Za Zhi. 13:9–11. 2010.(In Chinese).
|
|
4
|
Wang FX, Jiang ZM, Huang ZW, Han F, Jin YL
and Qiao XL: EAPA turn neck test and research of prognosis of
vertebral-basilar artery blood supply insufficiency. Zhong Feng Yu
Shen Jing Ji Bing Za Zhi. 1:3761994.(In Chinese).
|
|
5
|
Wang XJ: 50 cases of curative effect
observation of puerarin combined with sibelium in the treatment of
vertebrobasilar ischemia vertigo. Baiqiuen Jun Yi Xue Yuan Za Zhi.
7:301–302. 2009.(In Chinese).
|
|
6
|
Kang YQ and Li ZY: Clinical analysis of
vertebrobasilar ischemia. Di Si Jun Yi Da Xue Jilin Jun Yi Xue Yuan
Xue Bao. 22:84–87. 2000.(In Chinese).
|
|
7
|
Wong KH, Li GQ, Li KM, Razmovski-Naumovski
V and Chan K: Kudzu root: Traditional uses and potential medicinal
benefits in diabetes and cardiovascular diseases. J Ethnopharmacol.
134:584–607. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou YX, Zhang H and Peng C: Puerarin: A
review of pharmacological effects. Phytother Res. 28:961–975. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shi CY, Zhao LX and Guan HY: 102 cases of
puerarin for treatment of vertebral basilar artery insufficiency
vertigo. Shaanxi Zhong Yi. 12:1324–1325. 2005.(In Chinese).
|
|
10
|
Yao LY: Curative effect observation of
alprostadil combined with shuxuening in the treatment of posterior
circulation ischemic vertigo. Zhongguo Shi Yong Shen Jing Ji Bing
Za Zhi. 15:56–57. 2012.(In Chinese).
|
|
11
|
Hsu FL, Liu IM, Kuo DH, Chen WC, Su HC and
Cheng JT: Antihyperglycemic effect of puerarin in
streptozotocin-induced diabetic rats. J Nat Prod. 66:788–792. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Meng QH, Zhang YM and Lou FL: Mechanisms
of inflammation in AD rats induced by αβ and the intervention
effect of acetyl puerarin and chitosan phosphatidylcholine.
Shandong University. 2013.(In Chinese).
|
|
13
|
Wang XX, Zhang YL and Wu J: The effects of
puerariae radix on bone mass and bone microarchitecture in
ovariectomy mice. Zhongguo Guzhi Shusong Zazhi. 14:349–354.
2008.(In Chinese).
|
|
14
|
Miyazawa M, Sakano K, Nakamura S and
Kosaka H: Antimutagenic activity of isoflavone from Pueraria
lobata. J Agric Food Chem. 49:336–341. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sun XH, Ding JP, Li H, Pan N, Gan L, Yang
XL and Xu HB: Activation of large-conductance calcium-activated
potassium channels by puerarin: The underlying mechanism of
puerarin-mediated vasodilation. J Pharmacol Exp Ther. 323:391–397.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fan LL, Sun LH, Li J, Yue XH, Yu HX and
Wang SY: The protective effect of puerarin against myocardial
reperfusion injury. Study on cardiac function. Chin Med J (Engl).
105:11–17. 1992.PubMed/NCBI
|
|
17
|
Xu X, Zhang S, Zhang L, Yan W and Zheng X:
The Neuroprotection of puerarin against cerebral ischemia is
associated with the prevention of apoptosis in rats. Planta Med.
71:585–591. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guerra MC, Speroni E, Broccoli M, Cangini
M, Pasini P, Minghett A, Crespi-Perellino N, Mirasoli M,
Cantelli-Forti G and Paolini M: Comparison between Chinese medical
herb Pueraria lobata crude extract and its main isoflavone
puerarin antioxidant properties and effects on rat liver
CYP-catalysed drug metabolism. Life Sci. 67:2997–3006. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yu Z and Li W: Induction of apoptosis by
puerarin in colon cancer HT-29 cells. Cancer Lett. 238:53–60. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang Y, Zeng X, Zhang L and Zheng X:
Stimulatory effect of puerarin on bone formation through activation
of PI3K/Akt pathway in rat calvaria osteoblasts. Planta Med.
73:341–347. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun XJ and Dang XR: Curative effect
observation of betahistine combined with puerarin in the treatment
of vertebrobasilar ischemia vertigo. Di 4 Jun Yi Da Xue Xue Bao.
28:22772007.(In Chinese).
|
|
22
|
Yue YM, Qiao B and Zhang YH: 46 cases
analysis of curative effect of puerarin combined with betahistine
in the treatment of vertebrobasilar ischemia vertigo. Zhongguo Yi
Xue Chuang Xin. 10:53–54. 2013.(In Chinese).
|
|
23
|
Yang MG: Curative effect observation of
betahistine combined with puerarin in the treatment of
vertebrobasilar ischemia vertigo. Hebei Yi Yao. 32:3170–3171.
2010.(In Chinese).
|
|
24
|
Wang L: Curative effect observation of
betahistine combined with puerarin in the treatment of
vertebrobasilar ischemia vertigo. Dang Dai Yi Xue. 17:1092011.(In
Chinese).
|
|
25
|
Xie SB: Curative effect observation of
betahistine combined with puerarin in the treatment of
vertebrobasilar ischemia vertigo. Shi Yong Yi Xue Za Zhi.
24:2323–2324. 2008.(In Chinese).
|
|
26
|
Guo R: Curative effect of puerarin
combined with betahistine in the treatment of 43 cases of
vertebrobasilar ischemia vertigo. Zhongguo Shi Yong Shen Jing Ji
Bing Za Zhi. 15:61–62. 2012.(In Chinese).
|
|
27
|
Lei LF: Curative effect of puerarin
combined with betahistine in the treatment of 43 cases of
vertebrobasilar ischemia vertigo. Zhongguo Zhong Yi Ji Zheng.
17:1143–1144. 2008.(In Chinese).
|
|
28
|
Qiao D and Ma YZ: Curative effect
observation of puerarin injection in the treatment of
vertebrobasilar ischemia vertigo. Shijie Zhong Xi Yi Jie He Za Zhi.
3:1632008.(In Chinese).
|
|
29
|
Zhang JR: 60 cases of curative effect
observation of puerarin combined with lidocaine in the treatment of
vertebrobasilar ischemia vertigo. Xian Dai Zhong Xi Yi Jie He Za
Zhi. 14:6012005.(In Chinese).
|
|
30
|
Altman DG and Riley RD: Primer: An
evidence-based approach to prognostic markers. Nat Clin Pract
Oncol. 2:466–472. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Trivella M, Pezzella F, Pastorino U,
Harris AL and Altman DG: Prognosis In Lung Cancer (PILC)
Collaborative Study Group: Microvessel density as a prognostic
factor in non-small-cell lung carcinoma: A meta-analysis of
individual patient data. Lancet Oncol. 8:488–499. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cheung F, Feng Y, Wang N, Yuen MF, Tong Y
and Wong VT: Effectiveness of Chinese herbal medicine in treating
liver fibrosis: A systematic review and meta-analysis of randomized
controlled trials. Chin Med. 7:52012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
American Heart Association:
Recommendations on stroke prevention, diagnosis, and therapy.
Report of the WHO Task Force on Stroke and other Cerebrovascular
Disorders. Stroke. 20:1407–1431. 1989.PubMed/NCBI
|
|
34
|
Green S: Cochrane Handbook for Systematic
Reviews of Interventions. The Cochrane Collaboration. 2011.
|
|
35
|
Jadad AR, Moore RA, Carroll D, Jenkinson
C, Reynolds DJ, Gavaghan DJ and McQuay HJ: Assessing the quality of
reports of randomized clinical trials: Is blinding necessary?
Control Clin Trials. 17:1–12. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Qin F, Liu JY and Yuan JH:
Chaihu-Shugan-San, an oriental herbal preparation, for the
treatment of chronic gastritis: A meta-analysis of randomized
controlled trials. J Ethnopharmacol. 146:433–439. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Petitti DB: Approaches to heterogeneity in
meta-analysis. Stat Med. 20:3625–3633. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sutton AJ, Duval SJ, Tweedie RL, Abrams KR
and Jones DR: Empirical assessment of effect of publication bias on
meta-analyses. BMJ. 320:1574–1577. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Higgins JPT and Green S: Cochrane Handbook
for Systematic Reviews of Interventions. Version 4.2.6. The
Cochrane Collaboration. 2006.
|
|
40
|
Du YQ and Wang XJ: Ozagrel sodium combined
with buflomedil treat vertebrobasilar ischemia vertigo. Dang Dai Yi
Xue. 15:1332009.(In Chinese).
|
|
41
|
Xiao HX: Pharmacological research status
of Pueraria lobata. Shizhen Guo Yi GuoYao. 12:11412000.(In
Chinese).
|
|
42
|
Liao ML, Yu J and Zhou M: New progress of
Puerarin in clinical application. Xian Dai Zhong Xi Yi Jie He Za
Zhi. 12:7762003.(In Chinese).
|
|
43
|
Lei BX, Hou XL and Wang JP: Effect of
anti-cerebral ischemia and hypoxia of kudzu. Zhongguo Yiyuan Yao
Xue Za Zhi. 20:152000.(In Chinese).
|
|
44
|
Yang X, Xiong X, Yang G and Wang J:
Chinese patent medicine Xuefu Zhuyu capsule for the treatment of
unstable angina pectoris: A systematic review of randomized
controlled trials. Complement Ther Med. 22:391–399. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Turner L, Shamseer L, Altman DG, Schulz KF
and Moher D: Does use of the CONSORT Statement impact the
completeness of reporting of randomised controlled trials published
in medical journals? A Cochrane review. 1:602012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Turner L, Shamseer L, Altman DG, Weeks L,
Peters J, Kober T, Dias S, Schulz KF, Plint AC and Moher D:
Consolidated standards of reporting trials (CONSORT) and the
completeness of reporting of randomised controlled trials (RCTs)
published in medical journals. Cochrane Database Syst Rev.
11:MR0000302012.PubMed/NCBI
|
|
47
|
Xiong X, Yang X, Liu W, Feng B, Ma J, Du
X, Wang P, Chu F, Li J and Wang J: Banxia baizhu tianma decoction
for essential hypertension: A systematic review of randomized
controlled trials. Evid Based Complement Alternat Med.
2012:2714622012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Xiong X, Yang X, Feng B, Liu W, Duan L,
Gao A, Li H, Ma J, Du X, Li N, et al: Zhen gan xi feng decoction, a
traditional Chinese herbal formula, for the treatment of essential
hypertension: A systematic review of randomized controlled trials.
Evid Based Complement Alternat Med. 2013:9823802013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Smith SM, Chang RD, Pereira A, Shah N,
Gilron I, Katz NP, Lin AH, McDermott MP, Rappaport BA, Rowbotham
MC, et al: Adherence to CONSORT harms-reporting recommendations in
publications of recent analgesic clinical trials: An ACTTION
systematic review. Pain. 153:2415–2421. 2012. View Article : Google Scholar : PubMed/NCBI
|
